We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$16.8B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$88.2B
AUM Growth
+$1.6B
(+1.9%)
Cap. Flow
-$4.17B
Cap. Flow
% of AUM
-4.73%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
1,971
New
331
Increased
444
Reduced
869
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$314M |
| 2 |
TSMC
TSM
|
+$302M |
| 3 |
Genuine Parts
GPC
|
+$301M |
| 4 |
First Industrial Realty Trust
FR
|
+$131M |
| 5 |
Dollar Tree
DLTR
|
+$92.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$354M |
| 2 |
ConocoPhillips
COP
|
+$339M |
| 3 |
Archer Daniels Midland
ADM
|
+$275M |
| 4 |
WNS
WNS Holdings
WNS
|
+$149M |
| 5 |
Paycom
PAYC
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.38% |
| 2 | Healthcare | 13.98% |
| 3 | Financials | 12.4% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Dianthus Therapeutics
DNTH
$5.68B
| $55 | ﹤0.01% |
+1,824
| New | +$39.6K |
|
1602
Dutch Bros
BROS
$8.78B
| $54 | ﹤0.01% |
+1,624
| New | +$47.9K |
|
1603
Diebold Nixdorf
DBD
$3.09B
| $53 | ﹤0.01% |
+1,549
| New | +$49.7K |
|
1604
Standard BioTools
LAB
$326M
| $53 | ﹤0.01% |
+19,608
| New | +$47.3K |
|
|
AIIO
1605
Robo.ai Inc
AIIO
$436M
| $53 | ﹤0.01% |
+421
| New | +$50.9K |
|
1606
Blend Labs
BLND
$409M
| $51 | ﹤0.01% |
+15,755
| New | +$42.5K |
|
1607
Sigma Lithium
SGML
$1.08B
| $50 | ﹤0.01% |
3,833
-54,782
| -93% | -$978K |
|
|
APLT
1608
DELISTED
Applied Therapeutics
APLT
| $46 | ﹤0.01% |
+6,736
| New | +$30.2K |
|
1609
Arhaus
ARHS
$1.12B
| $43 | ﹤0.01% |
+2,780
| New | +$35.8K |
|
1610
Fulcrum Therapeutics
FULC
$248M
| $41 | ﹤0.01% |
+4,365
| New | +$39K |
|
|
ADVM
1611
DELISTED
Adverum Biotechnologies
ADVM
| $37 | ﹤0.01% |
+2,586
| New | +$39.3K |
|
|
DFTX
1612
Definium Therapeutics
DFTX
$5.73B
| $36 | ﹤0.01% |
+3,779
| New | +$21.5K |
|
1613
NB Bancorp
NBBK
$983M
| $36 | ﹤0.01% |
+2,612
| New | +$36.5K |
|
1614
Korro Bio
KRRO
$153M
| $35 | ﹤0.01% |
+389
| New | +$21.2K |
|
1615
Neurogene
NGNE
$696M
| $35 | ﹤0.01% |
+697
| New | +$23.3K |
|
|
TRML
1616
DELISTED
Tourmaline Bio
TRML
| $35 | ﹤0.01% |
+1,522
| New | +$53.7K |
|
|
DEC
1617
Diversified Energy Company
DEC
$914M
| $34 | ﹤0.01% |
+2,797
| New | +$35K |
|
1618
C4 Therapeutics
CCCC
$376M
| $33 | ﹤0.01% |
+4,009
| New | +$31.1K |
|
1619
Core Scientific
CORZ
$7.23B
| $33 | ﹤0.01% |
+9,272
| New | +$32.2K |
|
1620
Wheels Up
UP
$220M
| $32 | ﹤0.01% |
+565
| New | +$37.2K |
|
1621
Applied Optoelectronics
AAOI
$8.04B
| $31 | ﹤0.01% |
+2,207
| New | +$37.2K |
|
1622
American Superconductor
AMSC
$1.48B
| $29 | ﹤0.01% |
+2,143
| New | +$26.6K |
|
|
PLL
1623
DELISTED
Piedmont Lithium
PLL
| $29 | ﹤0.01% |
2,184
+1,800
| +469% | +$28.9K |
|
1624
Absci
ABSI
$1.28B
| $28 | ﹤0.01% |
+4,879
| New | +$22K |
|
1625
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $28 | ﹤0.01% |
+54
| New | +$26.9K |
|
Similar funds
AIMCA
CI
BCIM
VMPIC
EIP
PP
ASRS
CM
Macquarie Group's Q1 2024 Portfolio in Review
As of Q1 2024, Macquarie Group held 1,971 positions worth $88.2B, up 1.9% from $86.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Macquarie Group withdrew a net $4.17B in Q1 2024, closing 74 positions and reducing 869 holdings. Its most notable exit was Littelfuse, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Macquarie Group opened a new position in Nextpower Inc worth $71.7M.
- Macquarie Group's largest Q1 2024 buy was Nextpower Inc: 1,273,463 shares worth $71.7M.
- Macquarie Group added most to ExxonMobil in Q1 2024, an estimated $314M increase.
- Macquarie Group's biggest Q1 2024 reduction was RTX Corp, cutting an estimated $354M.
- Macquarie Group fully exited Littelfuse in Q1 2024, selling an estimated $122M.
- Macquarie Group's ten largest holdings make up 15% of its $88.2B portfolio in Q1 2024.
- Macquarie Group opened 331 new positions and closed 74 in Q1 2024.
- Macquarie Group's portfolio value rose 1.9% quarter-over-quarter to $88.2B.
Based on Macquarie Group's 13F filing for Q1 2024, filed 14 May 2024.